Figure S4. The inverse proportional change of Ly6Chi macrophages and CD206+ M2 macrophages from the inflammation stage (day 7) to the fibrotic stage (day 21). The single-cell suspension obtained from the back skin of bleomycin-injected C57BL/6 mice on day 7 and day 21 was stained with the mAbs against CD45, CD11b, Ly6C, and CD206. Stained samples were analyzed using the FACSCanto II system. Data were analyzed using FlowJo software version 7. All values represent mean ± SEM. n = 3 at each time point. ** p ≤ 0.01. (PDF 49 kb
GPR120 agonist accelerates wound repair in a mouse skin defected model. (A) Representative images an...
Characterization of surface markers on M0, M1-, and M2-polarized macrophages derived from peripheral...
Abatacept alleviates gut involvement in experimental cGvHD. Representative images of inflammatory ce...
Figure S3. Every-other-day injection of bleomycin for 2 weeks induced significant skin fibrosis. Bac...
Figure S2. HPH-15 treatment did not affect the growing of the mice. The body weight changes of mice ...
Abatacept alleviates lung fibrosis in the Fra-2 mouse model. Representative images of second harmoni...
Scatterplots of Fig. 1b. Scatterplots of the proportions of IL-4-, IL-13-, IL17A-, and IFN-γ-produ...
Abatacept alleviates inflammation-driven fibrosis by suppressing the immune response. Schematic cart...
Figure S2. In vitro stimulation of BMDM with IFNγ+LPS or IL4 resulted in differentiation into classi...
Table S1. Specifications of primary antibodies. Table S2. Primers used for q-PCR. Figure S1. Pulmona...
Additional file 3. Experimental data. Skin fibrosis reduced after administering mASCs. 1×105 mASCs a...
Effect of TLR or cytokine stimulation on surface marker expression in M1 versus M2 macrophages deriv...
Induction of skin fibrosis in the murine bleomycin skin model. (A) shows the increase in dermal thic...
Synovial cell populations from joints at week 1 from WT, Irf4 −/− , Ccl17 E/E and GM-CSF −/− mice un...
Figure S5. Inhibition of NF-κB activity suppressed TPA-induced skin inflammation. WT and IL-32γ mice...
GPR120 agonist accelerates wound repair in a mouse skin defected model. (A) Representative images an...
Characterization of surface markers on M0, M1-, and M2-polarized macrophages derived from peripheral...
Abatacept alleviates gut involvement in experimental cGvHD. Representative images of inflammatory ce...
Figure S3. Every-other-day injection of bleomycin for 2 weeks induced significant skin fibrosis. Bac...
Figure S2. HPH-15 treatment did not affect the growing of the mice. The body weight changes of mice ...
Abatacept alleviates lung fibrosis in the Fra-2 mouse model. Representative images of second harmoni...
Scatterplots of Fig. 1b. Scatterplots of the proportions of IL-4-, IL-13-, IL17A-, and IFN-γ-produ...
Abatacept alleviates inflammation-driven fibrosis by suppressing the immune response. Schematic cart...
Figure S2. In vitro stimulation of BMDM with IFNγ+LPS or IL4 resulted in differentiation into classi...
Table S1. Specifications of primary antibodies. Table S2. Primers used for q-PCR. Figure S1. Pulmona...
Additional file 3. Experimental data. Skin fibrosis reduced after administering mASCs. 1×105 mASCs a...
Effect of TLR or cytokine stimulation on surface marker expression in M1 versus M2 macrophages deriv...
Induction of skin fibrosis in the murine bleomycin skin model. (A) shows the increase in dermal thic...
Synovial cell populations from joints at week 1 from WT, Irf4 −/− , Ccl17 E/E and GM-CSF −/− mice un...
Figure S5. Inhibition of NF-κB activity suppressed TPA-induced skin inflammation. WT and IL-32γ mice...
GPR120 agonist accelerates wound repair in a mouse skin defected model. (A) Representative images an...
Characterization of surface markers on M0, M1-, and M2-polarized macrophages derived from peripheral...
Abatacept alleviates gut involvement in experimental cGvHD. Representative images of inflammatory ce...